Compounded medications are legal when prescribed by a licensed provider and dispensed by a licensed compounding pharmacy
However, both peptides were effective, and the difference was not large
This is a significant advancementtraditionally, peptides had to be injected
Phase 1 (Weeks 1 to 2): 0.25 mg subcutaneous injection once daily, morning on empty stomach Phase 2 (Weeks 3 to 6): Maintain 0.25 mg or increase to 0.5 mg based on response and tolerance Phase 3 (Weeks 7 to 8): Continue or begin taper depending on symptom improvement Maintenance: Consider cycling 4 weeks on, 2 weeks off for long-term management Oral dosing requires higher amounts to compensate for bioavailability differences
Timeline: What to Expect Connective-tissue and skin effects in the underlying peptide literature are cumulative reported over weeks, not overnight
By adhering to these practices, peptides can remain stable and functional for years, ensuring reliable experimental results